Power Law company profile

Forty Seven

Biotech & Life Sciences · Menlo Park, United States · Founded 2015 · IPO 2018 Unicorn

Advancement of immuno-oncology through the engagement of new and complementary phagocytic pathways

Valuation

$4.90B

Market cap · 2026

Revenue

$16M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

4 investors on Forty Seven's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

Clarus Ventures

Lightspeed Venture Partners

Sutter Hill Ventures

Series B+ 1 investor entered at this stage

Wellington Management

Global footprint

Where Forty Seven has talent and traffic

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Web traffic by country

2K monthly visits
across markets

🇺🇸 United States85%

🇩🇪 Germany15%

🇮🇳 India0%

🇮🇩 Indonesia0%

Top 4 markets shown

Patent intelligence

$83M patent portfolio · 24 active families

Estimated portfolio value

$83M

1.7% of market cap · 3.9× smaller than top peer Genmab ($328M)

24 active patent families

Where Forty Seven innovates Antiendomysial antibodiesImmunologyMolecular biologyCancer researchCD47

Where Forty Seven concentrates vs peers

Each axis is a top-10 topic across Forty Seven and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Forty Seven

An AI-synthesized read of the highest-engagement posts about Forty Seven on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Forty Seven on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles